---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-26-060600"
form_type: "8-K"
ticker: "SNTI"
cik: "0001854270"
company_name: "Senti Biosciences, Inc."
filed_at: "2026-09-04T10:01:29+00:00"
generated_at: "2026-09-04T10:05:21.338875+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Senti Biosciences issues $2M convertible notes, secures $2.5M equity commitment from Celadon affiliate

## Summary
- Issued $2.0M aggregate principal Senior Secured Convertible Notes to NSG BioInnovation Fund on Sept 3, 2026.
- Notes mature Nov 23, 2026, repayable at 200% of principal; 12% default interest rate applies upon event of default.
- Entered equity commitment letter with Celadon affiliate (CPIF II-9 Limited) to purchase $2.5M common stock at Nasdaq Minimum Price.
- Shares to be purchased at closing of merger with Celadon affiliate; contingent value right up to $60M cash tied to SENTI-202 milestones.
- Merger and CVR subject to stockholder approval; definitive proxy statement to be mailed after filing with SEC.

## SEC filing metadata
- accession: 0001628280-26-060600
- form_type: 8-K
- ticker: SNTI
- cik: 0001854270
- company_name: Senti Biosciences, Inc.
- filed_at: 2026-09-04T10:01:29+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 1.01, 2.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1854270/000162828026060600/0001628280-26-060600-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1854270/000162828026060600/snti-20260903.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-26-060600
- JSON: https://secwatch.observer/filing/0001628280-26-060600.json
- Plain text: https://secwatch.observer/filing/0001628280-26-060600.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.